This Elevance Health Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday
Wall Street analysts upgraded TIGO, MWH, CNX, TNDM and ELV, with mixed price-target changes.
Follow the latest Praxis Precision Medicines, Inc. (PRAX) news and market headlines alongside the live PRAX price. Stay informed on what's moving PRAX.
Wall Street analysts upgraded TIGO, MWH, CNX, TNDM and ELV, with mixed price-target changes.
Analysts upgraded UNFI, ZBH, NUE, MDT and PRAX, raising price targets and ratings to Buy or Overweight.
Wells Fargo analyst Benjamin Burnett upgrades Praxis Precision Medicine (NASDAQ:PRAX) from Equal-Weight to Overweight and raises the price target from $343 to $509.
Guggenheim analyst Yatin Suneja maintains Praxis Precision Medicine (NASDAQ:PRAX) with a Buy and raises the price target from $800 to $1050.
Baird analyst Joel Beatty maintains Praxis Precision Medicine (NASDAQ:PRAX) with a Outperform and raises the price target from $514 to $568.
News and data on this page is provided by our partnered third-party news and market data provider, with the original publisher credited on each article. All third-party content reflects the views of the original publisher and does not represent the views of MEXC. Price and market data shown on this page are provided by third-party data providers and may be delayed. MEXC offers trading products related to PRAX, including RealStocks and Stock Futures.
The content on this page is provided for informational purposes only and does not constitute investment, financial, or trading advice. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of any news or market data shown. Trading U.S. stocks and related products involves significant risk, and prices can move sharply in a short period. Past performance does not guarantee future results. Please conduct your own research and assess your financial situation and risk tolerance before making any investment decisions. MEXC is not liable for any losses arising from the use of this information.